MicroRNA regulation of bovine monocyte inflammatory and metabolic networks in an in vivo infection model. by Lawless, Nathan et al.
Title: MicroRNA regulation of bovine monocyte inflammatory and metabolic 
networks in an in vivo infection model.  
 
Authors: 
Nathan Lawless*§ 
Timothy A. Reinhardt † 
Kenneth Bryan * 
Mike Baker ‡ 
Bruce Pesch † 
Duane Zimmerman † 
Kurt Zuelke ** 
Tad Sonstegard §§ 
Cliona O’Farrelly § 
John D. Lippolis † 
David J. Lynn * 
 
Affiliations: 
 
*Animal & Bioscience Research Department, Animal & Grassland Research and 
Innovation Centre, Teagasc, Grange, Dunsany, Co. Meath, Ireland. 
 
§School of Biochemistry & Immunology, Trinity College, Dublin 2, Ireland. 
 
† USDA-ARS, National Animal Disease Center, Ames, IA, 50010 USA. 
 
 1 
 G3: Genes|Genomes|Genetics Early Online, published on January 27, 2014 as doi:10.1534/g3.113.009936
© The Author(s) 2013. Published by the Genetics Society of America. 
‡ Iowa State University, DNA Facility, Molecular Biology Building, Ames, IA, 50010 
USA.  
 
** Australian Animal Health Laboratory, CSIRO, East Geelong VIC 3219, Australia 
 
§§ USDA-ARS, Beltsville, MD, 20705-1350, USA.  
 
NCBI GEO database and assigned the identifier (GSE51858). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Short title: mRNA & miRNA expression in bovine monocytes. 
 
Corresponding Authors: David Lynn, Animal & Bioscience Research Department, 
Animal & Grassland Research and Innovation Centre, Teagasc, Grange, Dunsany, Co. 
Meath, Ireland. +353(0)469026729, david.lynn@teagasc.ie. John Lippolis, USDA-
ARS, National Animal Disease Center, Ames, IA, 50010 USA, +5153377446, 
john.lippolis@ars.usda.gov. 
 
Infection/Innate immunity/RNAseq/microRNA/Transcriptional networks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
ABSTRACT 
 
Bovine mastitis is an inflammation-driven disease of the bovine mammary gland that 
costs the global dairy industry several billion dollars per annum. Because disease 
susceptibility is a multi-factorial complex phenotype, an integrative biology approach 
is required to dissect the molecular networks involved. Here, we report such an 
approach, using next generation sequencing combined with advanced network and 
pathway biology methods to simultaneously profile mRNA and miRNA expression at 
multiple time-points (0, 12, 24, 36 and 48h) in both milk and blood FACS-isolated 
CD14+ monocytes from animals infected in vivo with Streptococcus uberis. More 
than 3,700 differentially expressed (DE) genes were identified in milk-isolated 
monocytes (MIMs), a key immune cell recruited to the site of infection during 
mastitis. Up-regulated genes were significantly enriched for inflammatory pathways, 
while down-regulated genes were enriched for non-glycolytic metabolic pathways. 
Monocyte transcriptional changes in the blood, however, were more subtle but 
highlighted the impact of this infection systemically. Genes up-regulated in blood-
isolated-monocytes (BIMs) showed a significant association with interferon and 
chemokine signalling. Furthermore, twenty-six miRNAs were differentially expressed 
in MIMs and three in BIMs. Pathway analysis revealed that predicted targets of down-
regulated miRNAs were highly enriched for roles in innate immunity (FDR < 3.4E-8) 
in particular TLR signalling, while up-regulated miRNAs preferentially targeted 
genes involved in metabolism. We conclude that during S. uberis infection miRNAs 
are key amplifiers of monocyte inflammatory response networks and repressors of 
several metabolic pathways.  
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INTRODUCTION 
 
Bovine mastitis is an inflammation-driven disease of the bovine mammary gland that 
is associated with very significant costs to the global dairy industry. In Europe this 
cost is estimated to be approximately €2 billion/annum (Wells et al., 1998), with 
similar figures available for the USA (Jones, 2009). Causative agents of mastitis 
infection include, but are not limited to coliforms (E. coli), Streptococci (S. uberis) 
and Staphylococci (S. aureus). Streptococcus uberis is now ranked amongst the most 
prevalent mastitis causing pathogens throughout the EU and in North America 
(Reinoso et al., 2011; Ward et al., 2009).  
 Mastitis develops as bacteria entering the udder via the teat canal stimulate a 
pathological form of inflammation. Bacteria encounter epithelial cells lining the 
mammary gland stimulating a local inflammatory response which facilitates their 
transport across the epithelial barrier where they are detected by resident immune 
cells, such as monocytes. Both cell types constitutively express surface pathogen 
recognition molecules such as Toll-like Receptors (TLRs) enabling them to function 
in a sentinel capacity. Invasive S. uberis triggers TLR2 and 4 mobilising local and 
systemic inflammatory mediators (Bannerman et al., 2004; Moyes et al., 2009). 
Typically, chemokines, interleukins (ILs) and tumour necrosis factor α (TNF) initiate 
local physiological changes in vascular permeability, cell differentiation, and 
apoptosis. Concurrently, systemic innate immune changes provoke acute phase 
protein (APP) production which is distributed systemically to suppress the spread of 
bacteria locally (Mitterhuemer et al., 2010). During this phase, immune cells are 
recruited to the point of infection (Rinaldi et al., 2010). Monocytes are released from 
the bone marrow into the circulatory system and eventually reach the mammary gland 
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via chemokine ligand-mediated cell migration. There they differentiate into 
macrophage and dendritic cell populations (Dong et al., 2013; Shi & Pamer, 2011). 
Neutrophils make up the majority of immune cells in an infected gland during an 
infection. Neutrophils are tasked with directly clearing invasive bacteria via 
phagocytosis or neutrophil extracellular traps (NETS) and subsequently aid in 
resolution of inflammation (Lippolis et al., 2006; Reinhardt et al., 2013). Once 
recruited to the site of infection, monocytes and neutrophils orchestrate antimicrobial 
activity to control bacterial spread and resolve the infection (Dong et al., 2013; 
Serbina et al., 2008). Immune cells and other somatic cells can be detected in the milk 
of infected animals and the counts of the number of such somatic cells per ml, called 
the somatic cell count, is an indicator of mastitis (Jones, 2009).  
 The local immune response in mammary tissues has been examined by several 
approaches both in vivo & in vitro. Candidate gene based approaches and microarray 
technology have determined that over 2,000 genes spanning immunity, metabolism, & 
tissue remodelling are active during mastitis (Mitterhuemer et al., 2010; Moyes et al., 
2009; Swanson et al., 2009). Modest data is, however, available examining 
transcriptional activity in either milk or blood monocytes from infected animals 
(Prgomet et al., 2005) and little is known regarding the role microRNAs play in 
regulating these responses.  
 MicroRNAs (miRNAs) are small, non-coding RNAs, which play a key role in 
the regulation of innate and adaptive immunity as post-transcriptional regulators of 
gene expression (O'Connell et al., 2010). They have been shown to regulate immune 
function in several cell types. Neutrophil senescence, for example, is regulated by a 
discrete miRNA repertoire (Ward et al., 2011). Naïve mouse B cells are indirectly 
regulated by miR-155 via histone deacetylase 4 repression, while naive CD4+ T cell 
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differentiation and function is regulated by global changes in miRNAs (Bronevetsky 
et al., 2013; Sandhu et al., 2012). In a recent study, we concluded that miRNAs likely 
play a key role in regulating the innate immune response in mammary epithelial cells 
to a bovine mastitis pathogen in vitro (Lawless et al., 2013).  
 Although miRNA expression is abundant in numerous bovine tissues, 
genome-wide studies elucidating the regulatory roles of miRNAs in bovine immunity 
are limited (Coutinho et al., 2007; Jin et al., 2009; Xu et al., 2009). Furthermore, no 
bovine studies to date have applied next generation sequencing (NGS) to examine 
global miRNA expression in immunity and infection in vivo. In this study, we report a 
NGS approach to profile the expression of bovine miRNAs & mRNAs at multiple 
time-points in milk and blood isolated CD14+ monocyte cells isolated from Holstein 
Friesians infected in vivo with Streptococcus uberis a causative agent of bovine 
mastitis. 
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MATERIALS AND METHODS 
 
Animals 
 
10 female Holstein Friesians in the middle of their first lactation period, aged between 
26-30 months, and 3-5 months post-partum, were selected for this study. The trial was 
conducted at the USDA National Animal Disease Centre (NADC) Ames, Iowa. All 
animals had a medical history that was free from mastitis. The National Animal 
Disease Centre’s Animal Care and Use Committee approved all procedures used in 
this study. 
 
Infection Protocol 
 
Five animals were infected via the teat canal of the right front quarter with 
approximately 500 colony forming units (CFU) of a mastitis-causing pathogen, 
Streptococcus uberis 0140, in 10 ml of saline. Five control animals were inoculated 
with saline only. Milk and blood samples were obtained from each animal at 0, 12, 
24, 36 and 48 hrs post-infection (or mock infection) as described below. At each time 
point rectal temperature, total volume of milk, somatic cell count, bacterial counts, 
ambient temperature, humidity, and additional observations were recorded for each 
animal. Bacterial counts were determined from 5 ml milk samples collected 
aseptically from the infected quarter. Milk was serially diluted in sterile phosphate-
buffered saline and spread on blood agar plates, then incubated for 24 h at 37 °C. 
Following incubation, plates were examined for bacterial growth and colony forming 
units (CFU) per ml were determined. 
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Cell Extraction from Milk 
 
Milk was collected using a sterilised quarter milker from infected and control animals 
at each time-point. The total volume of milk was noted. 5ml of milk was isolated for 
milk bacteriology. The remaining milk was then diluted into Hanks balanced salt 
solution w/o Ca, Mg, Phenol red (HBSS) + 10 mM EDTA. The mixture was inverted 
several times, and transferred to a 1l centrifuge bottle and centrifuged in a fixed angle 
rotor at 10,000 x g for 30 mins. After centrifugation the supernatant was poured off 
and the pellets were resuspended in 150 ml of HBSS + 5 mM EDTA. The 
resuspended pellets were then transferred to fresh centrifuge tubes and spun at 2500 x 
g for 30 mins. After the second spin, the supernatant was poured off and the pellet 
from each sample was resuspended in 20ml of RPMI 1640 + 1 mM Sodium Pyruvate 
+ 2 mM l Glutamine + 50 ug/ml Gentamycin + 10% FBS (cRPMI) (Sigma-Aldrich, 
Steinheim, Germany). The 20 ml of cell suspension was divided into 2 x 10 ml 
aliquots in 15ml conical centrifuge tubes. The cells were pelleted by centrifuge @ 650 
x g. After this spin the pellets were pooled into 4ml of cRPMI and were labelled for 
cell sorting. The cells were counted by trypsin blue exclusion (Careforde, IL, USA) to 
determine the cell count. 
 
Cell Extraction from Blood 
 
At each time-point, animals were lead into a crush, and 2x60cc syringes of blood were 
extracted by venipuncture and immediately placed on ice. The total volume of blood 
and total number of cells in blood were determined using a haemocytometer. Blood 
was spun for 20 mins at 1200 x g. The buffy coat was observed between serum and 
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red blood cell phase, and removed. Contaminating red blood cells were lysed by 
adding 1 volume lysis solution (10.6mM Na2HPO4; 2.7mM NaH2PO4) and inverting 
the tubes several times immediately followed by adding ½ volume restore solution 
(10.6mM Na2HPO4; 2.7mM NaH2PO4; 460mM NaCl) and inverting the tubes. The 
buffy coat was then spun for 10 mins at 650 x g, and the red supernatant was poured 
off. Cells were re-suspended in red blood cell lysis solution and then restore solution 
again as above. Cell were spun for a further 5 mins at 650 x g, and re-suspended in 5-
10 ml of media.   
 
Isolation of CD14+ Monocytes by Flow Cytometry 
 
Milk and blood derived CD14+ monocytes were isolated by Fluorescence-activated 
cell sorting (FACS). Briefly, cells were labelled with monoclonal anti-bovine 
CD14 (Clone CAM36A, VMRD, Pullman, WA, USA) and a PE-conjugated anti-
mouse IgG1 antibody (Southern Biotechnology, Birmingham, AL, USA). Labelled 
cells were separated based on fluorescence intensity using the BD FACS Aria Cell 
Sorting System (BD Biosciences, CA, USA). Cells with greater than 95% purity were 
isolated from the milk and peripheral blood of each animal. 
 
mRNA Extraction 
 
The mirVanaTM RNA Isolation Kit (Ambion, TX, USA.) was used to extract total 
RNA from FACS-isolated cell populations. Procedures were performed according to 
the manufacturer’s protocol (File S1). RNA was quantified, and integrity confirmed 
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using an Agilent RNA Kit on a 2100 Bioanalyzer platform (Agilent Technologies, 
CO, USA) (File S1).   
 
miRNA Extraction 
 
MicroRNA was extracted using mirPremierTM microRNA Isolation Kits (Sigma-
Aldrich, Steinheim, Germany). Procedures were performed according to the 
manufacturer’s protocol (File S1). Small RNA was quantified using an Agilent small 
RNA Kit on a 2100 Bioanalyzer platform (File S1). 
 
mRNA Library Generation  
 
One hundred indexed mRNA libraries (50 blood monocyte and 50 milk monocyte 
libraries) were prepared for cluster generation using TruSeq v2 RNA sample 
preparation kits (Illumina, CA, USA). Procedures were performed according to the 
manufacturer’s protocol (File S1). The finished libraries were validated on an Agilent 
Bioanalyzer 2100 using an Agilent DNA-1000 chip (Agilent, CO, USA), at which 
point they were loaded for cluster generation. The samples were sequenced on an 
Illumina HiSeq 2000 at the Iowa State Sequencing Centre (50bp single-end). Infected 
and control samples (n =100) were randomised across four flow cells (i.e. 3 or 4 
samples multiplexed per lane) to avoid confounding flow cell/lane effects (Auer & 
Doerge, 2010). The barcode compatibility chart provided with the TruSeq RNA 
sample preparation kit was adhered to when pooling libraries.  Fastq files were 
produced using the CASAVA 1.8 pipeline. 
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mRNAseq Analysis  
 
100 fastq files were generated containing the sequencing data for each of the 100 
mRNAseq libraries.  The quality and number of the reads for each sample were then 
assessed using FASTQC v0.10.0 
(http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/). Each sample was then put 
through a number of quality control filters. Firstly, reads were filtered using the fastq 
Illumina filter v0.1 (http://cancan.cshl.edu/labmembers/gordon/fastq_illumina_filter/), 
which removes reads from the fastq files which were flagged as not passing the 
Illumina CASAVA pipeline filters. Cutadapt v1.2 
(http://code.google.com/p/cutadapt/) was used to trim the adaptors from reads where 
necessary. The remaining reads were then further filtered using the fastq quality filter 
package (http://hannonlab.cshl.edu/fastx_toolkit/) v0.0.13.2. Reads where at least 
70% of the bases had a Phred score < 20 were removed. Reads passing all the above 
filters were also trimmed at their ends to remove low quality bases (Phred score < 20). 
Reads which were < 20 nt after trimming were discarded. Reads which passed all 
quality control steps were then aligned to the bovine genome (UMD3.1 assembly 
(Zimin et al., 2009)) using TopHat v 2.0.8 (Trapnell et al., 2009) allowing 1 
mismatch. Reads that did not uniquely align to the genome were discarded. HTSeq-
count version 0.5.3p3 
(http://wwwhuber.embl.de/users/anders/HTSeq/doc/overview.html) using the union 
model was used to assign uniquely aligned reads to Ensembl (v69) annotated bovine 
genes. 
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Differential Gene Expression Analysis 
 
Data was normalised across libraries using the trimmed mean of M-values (TMM) 
normalisation method (Bullard et al., 2010). The R (version 2.15.2) Bioconductor 
package EdgeR (v2.4.6) (Robinson et al., 2010), which uses a negative binomial 
distribution model to account for both biological and technical variability was applied 
to identify statistically significant differentially expressed genes. Any samples that 
had < 5 million uniquely aligning reads were removed from further analysis. Only 
genes that had at least 1 count per million in at least 3 samples were analysed for 
evidence of differential gene expression. The analysis was undertaken using 
moderated tagwise dispersions. Differentially expressed  genes were defined as 
having a fold change in gene expression > 1.5 and a Benjamini and Hochberg 
corrected FDR of < 0.05 (Benjamini & Hochberg, 1995).  
 
Hierarchical Clustering 
 
Hierarchical clustering of milk and blood mRNA normalised read counts were carried 
out in the R (version 2.15.2) hclust package. Heatmaps were generated using the R 
heatmap package.  
 
Gene Ontology and Pathway Analysis 
 
The R (version 2.15.2) Bioconductor package GOseq (version 1.10.0) which corrects 
for gene length bias (Young et al., 2010) was used to identify over-represented 
pathways using pathway annotation imported from the Kyoto Encyclopedia of Genes 
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and Genomes (KEGG) (Kanehisa et al., 2007) database. KEGG disease pathways 
were excluded to focus the analysis on primary signalling pathways. Pathways were 
considered significantly over-represented with an FDR < 0.05.  Pathway analysis was 
undertaken using Ensembl predicted human 1:1 orthologs of the bovine differentially 
expressed genes.  
 Additionally, we manually generated two pathway annotations that were of 
interest but not annotated in detail in KEGG; the “inflammasome” and “interferon” 
pathways. Gene IDs for these pathways were sourced from SA biosciences (Qiagen) 
RT² Profiler™ PCR Array Human Interferon and Receptors (PAHS-064A), and RT² 
Profiler™ PCR Array Human Inflammasome (PAHS-097A) annotations. The 
interferon pathway consisted of 84 genes (Table S1) whose expression is controlled 
by or involved in cell signalling mediated by interferon ligands and receptors, while 
the inflammasome pathway consisted of 95 key genes (Table S1) involved in the 
function of inflammasomes, protein complex’s involved in innate immunity, as well 
as general NOD-like receptor (NLR) signalling. 
 
Network Analysis Methods 
 
To generate molecular interaction networks, the human 1:1 orthologs of bovine 
genes that were differentially expressed, at least one of the four time-points, in milk 
isolated monocytes (MIMs) from S. uberis infected animals, were uploaded to 
InnateDB (www.innatedb.com) (Lynn et al., 2008). InnateDB is one of the most 
comprehensive databases of all human and mouse experimentally-supported 
molecular interactions (>300,000 interactions in July 2013) but also specifically 
includes annotation on more than 19,000 manually curated human and mouse innate 
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immunity relevant interactions, many of which are not present in any other database 
(Lynn et al., 2010). Networks were visualized using Cytoscape 2.8.2 (Shannon et 
al., 2003). 
 The network was analysed using the cytoHubba plugin (Lin et al., 2008) for 
Cytoscape 2.8.2 (Shannon et al., 2003) to identify network hubs and bottlenecks 
using default parameters. The jActiveModules plugin (Ideker et al., 2002) in 
Cytoscape 2.8.2 (Shannon et al., 2003) was also used to identify high-scoring 
differentially expressed sub-networks (Overlap Threshold = 0.3; Search depth = 3; 
Number of modules = 5; "Regional Scoring" and "Adjust score for size" both 
enabled). The InnateDB pathway analysis tool was used to identify over-
represented pathways among module genes.  
 
miRNA Library Generation 
 
One hundred indexed miRNA libraries (50 blood and 50 milk monocyte libraries) 
were also prepared for cluster generation and sequencing using the TruSeq Small 
RNA sample preparation kit. These miRNA libraries were prepared from the same 
samples that the mRNAseq libraries were prepared. Procedures were performed 
according to the manufacturer’s protocol (File S1). The finished libraries were 
validated on an Agilent Bioanalyzer 2100 using an Agilent DNA high sensitivity chip 
(Agilent, CO, USA), at which point they were loaded for cluster generation. The 
samples were sequenced on an Illumina HiSeq 2000 (50bp single-end). Infected and 
control samples (n =100) were randomised across three flow cells (i.e. 7 or 8 samples 
multiplexed per lane), to avoid confounding flow cell/lane effects (Auer & Doerge, 
2010). Fastq files were produced using the CASAVA 1.8 pipeline. In a few cases, the 
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sequenced miRNA libraries were found to be adaptor contaminated. These libraries 
were re-purified and re-sequenced. The list of re-sequenced samples can be found in 
the supplementary data section (Table S2).  
 
miRNAseq Analysis 
 
Preliminary quality control analysis of the 100 miRNAseq fastq files was again 
carried out with FASTQC software v0.10.0 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Cutadapt v1.2 
(code.google.com/p/cutadapt/) was then used to trim 3’ adaptor sequences. Reads 
which were shorter than 18 nucleotides after trimming were discarded. Trimmed reads 
were then further filtered using the fastq quality filter 
(http://hannonlab.cshl.edu/fastx_toolkit/) v0.0.13.2. Reads where at least 70% of the 
bases had a Phred score < 20 were removed (Cock et al., 2010). Finally, reads passing 
all the above filters were also trimmed at their ends to remove low quality bases 
(Phred score < 20). Reads which successfully passed filtering were aligned to the 
bovine genome (UMD3.1) using novoalign v2.08.03 in miRNA mode 
(http://www.novocraft.com) allowing 1 mismatch. Non-uniquely aligning reads were 
discarded. HTSeq version 0.5.3p3 (http://www-
huber.embl.de/users/anders/HTSeq/doc/overview.html) using the union model was 
used to assign uniquely aligned reads to miRBase v 19 miRNA annotation (Kozomara 
& Griffiths-Jones, 2011). The sequencing data from this publication have been 
submitted to the NCBI GEO database and assigned the identifier (GSE51858). 
 
 
 16 
Differential miRNA Expression Analysis  
 
Prior to assessing differential expression, miRNAseq count data were first normalised 
across libraries using either the trimmed mean of M-values (TMM) normalisation 
method (Robinson et al., 2010) or upper-quantile normalisation (Bullard et al., 2010). 
Differential expression analysis of miRNAseq data has been shown to be sensitive to 
the normalisation approach implemented (Garmire & Subramaniam, 2012). To 
address this issue, we identified differentially expressed miRNAs in two alternatively 
normalised datasets; TMM-normalised (Robinson et al., 2010), upper-quantile 
normalised and with no normalisation. Only miRNAs which were identified as 
differentially expressed across all three datasets were considered further i.e. the 
differential expression of these miRNAs was robust to the normalisation procedure 
(Lawless et al., 2013). Any samples that had < 2 million uniquely aligning reads were 
removed from further analysis. The R (version 2.15.2) Bioconductor package EdgeR 
(v2.4.6) (Robinson et al., 2010) was applied to identify statistically significant 
differentially expressed miRNAs. The analysis was undertaken using moderated 
tagwise dispersions. Differentially expressed miRNAs were defined as having a 
Benjamini and Hochberg corrected P value of < 0.05 (Benjamini & Hochberg, 1995).  
 
Co-expression and Target Analysis of miRNA and mRNA Data  
 
To identify mRNAs that were potentially regulated by differentially expressed (DE) 
miRNAs in MIMs, we first sought to calculate Pearson correlations, using the Apache 
commons Java statistics library, between all DE miRNA expression in reads per 
million (rpm) and all mRNA expression (TMM normalised read counts) over the 
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time-course. A correlation matrix was constructed consisting of 26 (DE miRNAs) x 
24,616 (All mRNAs) correlation coefficients. The resulting correlation matrix was 
then filtered to remove both non-significant correlations (critical value for Pearson’s 
correlation for this matrix is r = -0.3116) and those inverse correlations that were not 
supported by miRanda predicted miRNA-target pairs (miRanda v3.3a). The mRNAs 
predicted to be targeted (i.e. had a significant anti-correlation relationship in the 
expression of the mRNA and the miRNA, plus a predicted seed target) by either up- 
or down-regulated miRNAs were then selected for pathway analysis. Two-
dimensional cluster analysis and visualization, using R version 2.15.3 hclust and 
heatmap.plus packages, was then applied to the filtered correlation matrix.   
 
Pathway Analysis of Predicted miRNA Target Genes 
 
Target genes of differentially expressed miRNAs were submitted to InnateDB (Lynn 
et al., 2008) for pathway analysis. Genes were submitted in two groups; those that 
were targets of up-regulated miRNAs, and those that were targets of down-regulated 
miRNAs. Significant pathways were calculated based on hypergeometric analysis, 
pathways of interest were defined as having a Benjamini and Hochberg corrected P 
value of < 0.05 (Benjamini & Hochberg, 1995).      
 
Novel miRNA Discovery 
 
Using the software package miRDeep2 v0.0.5 (Mackowiak, 2011) we examined 
whether milk/blood monocytes encoded for miRNAs not yet annotated in the bovine 
genome. We further parsed this data using a number of different parameters to 
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identify those novel miRNAs that have the highest likelihood of being true positives 
as described previously (Lawless et al., 2013). Specifically, we identified those 
predictions where both the mature and star stands were expressed with a minimum of 
5 reads each; where miRDeep2 predicted that the miRNA had > 90% probability of 
being a true positive; where the hairpin structure had a significant Randfold p-value 
and where the novel miRNA was independently predicted in two or more different 
miRNAseq samples.  
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RESULTS 
 
The Kinetics of S. uberis Infection in vivo 
 
To investigate the host monocyte transcriptional and post-transcriptional response to a 
mastitis-causing pathogen in vivo, five Holstein Friesian animals were infected via the 
teat canal with approximately 500 CFU of Streptococcus uberis 0140, in 10 ml of 
saline. Five control animals were inoculated with saline only. Blood and milk samples 
were taken at 0, 12, 24, 36 and 48 hours post infection (hpi) and CD14+ monocytes 
were isolated by FACS (Figure 1). The infection was monitored using recorded milk 
bacterial counts (CFU/ml) and somatic cell counts (per ml) at each of the five time 
points for each animal (control & infected). On average, bacterial counts peaked in 
the infected animals at 24hpi, whereas no change was observed in the uninfected 
controls. There was, however, significant heterogeneity among the CFU data for each 
infected animal, in terms of the magnitude and the timing of the response (Figure 2A 
and Table S3). One infected animal (TI3 - which had the highest CFU/ml data) 
peaked at 24hpi, two others (TI1 and TI4) peaked at 36hpi and CFU data for one 
animal was still climbing at 48hpi (TI5). Additionally, one infected animal was 
observed to have only a very modest increase in bacterial counts (TI2). Somatic cell 
count (SCC) data also confirmed the presence of the infection in the challenged 
animals and not in the controls. SCC was observed to increase at 24hpi and by 36hpi 
was, on average, >900,000 cells/ml in infected animals. In comparison, the average 
SCC in control animals at 36hpi was <52,000 cells/ml (Figure 2B & Table S3). An 
SCC reading >200,000 cells/ml is generally considered diagnostic of mastitis (Dufour 
& Dohoo, 2013). Again there was heterogeneity in the SCC response in the infected 
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animals. Interestingly, the infected animal that was observed to have only a modest 
increase in CFU/ml (TI2) had a relatively robust SCC response.  
 
Profiling mRNA Expression in Blood and Milk Isolated CD14+ Monocytes 
 
A next generation sequencing approach was applied to monitor the transcriptional 
(mRNAseq) and post-transcriptional (miRNAseq) changes that occurred in both blood 
and milk isolated CD14+ monocytes in the infected and control animals (Figure 1). 
Sequencing of 100 mRNA Illumina libraries (i.e. 50 blood and 50 milk monocyte 
mRNA libraries) yielded >4 billion sequence reads. More than 3 billion reads of these 
mapped uniquely to the Bos taurus UMD 3.1 genome (Table S2). The average 
correlation coefficient of mRNA normalised read counts between samples at each 
time-point was 0.95 for control samples and 0.92 for infected samples indicating very 
high reproducibility of the data among replicates (Table S4). 
 Hierarchical Clustering of normalised mRNA read counts from MIMs 
revealed that the control and infected animals clearly separated at 36 and 48hpi except 
for the one infected sample (TI2) which had very low bacterial counts and likely did 
not developed a full infection (Figure 2C-F). This sample was subsequently excluded 
from differential gene expression analysis. Hierarchical Clustering of the normalised 
mRNA read counts of genes that were differentially expressed in blood isolated 
monocytes (BIMs) revealed that only 3 of the infected animals (TI1, TI3 and TI4) 
separated from uninfected controls at 36 and 48hpi (Figure S1). These animals also 
had the highest SCC data at these time-points.  
 We utilised the EdgeR statistical package (Robinson et al., 2010) to determine 
which mRNAs were significantly differentially expressed in MIMs and BIMs in 
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response to S. uberis. In MIMs, there were 4, 36, 1774, and 1532 up-regulated genes 
at 12, 24, 36 and 48hpi, respectively. The majority (1,254) of genes up-regulated at 
48hpi were also up-regulated at 36hpi. Additionally, there were 5, 2, 1518 and 995 
down-regulated genes in MIMs at those time-points. Of the 995 down-regulated genes 
at 48hpi, 80% were also down-regulated at 36hpi. Overall, 2056 different genes were 
up-regulated and 1721 different genes were down-regulated for at least one time-point 
in MIMs in response to S. uberis infection (Table S5).  
 Traditionally, mastitis has been thought of as a local bacterial infection with a 
robust inflammatory response. In BIMs, however, we observed a much more subtle 
but still quite significant response to S. uberis infection. Only, ten genes were up-
regulated in BIMs at 36hpi but this increased to 83 genes by 48hpi (Table S5). Nine 
of the ten 36hpi genes were also up-regulated at 48hpi. Additionally, 3, 4, 26, and 39 
genes were down-regulated in BIMs at 12, 24, 36 and 48hpi, respectively. 
 
Pathway Analysis Reveals the Suppression of Metabolic Pathways and the Up-
regulation of Inflammatory Pathways in Response to S. uberis Infection 
 
Pathway analysis of up- and down-regulated genes at each time-point was undertaken 
using GOseq (Young et al., 2010) with pathway annotation imported from the KEGG 
database (Kanehisa et al., 2007) to identify which pathways were statistically 
overrepresented among DE genes in MIMs and BIMs. Two manually curated 
pathways (Interferon signalling pathway and the Inflammasome pathway) were also 
included (see methods). No significant pathways were identified among either the 
BIM or MIM DE genes at 12 or 24hpi. At 36 and 48hpi, however, more than 20 
different pathways were identified as being statistically overrepresented (Figure 3 and 
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Table S6). In MIMs, down-regulated genes were predominantly associated with 
metabolic pathways (Figure S2), such as fatty acid and amino acid metabolism, the 
citric acid (TCA) cycle and glutathione metabolism, as well as DNA replication and 
repair pathways and the cell cycle. Down-regulated pathways were largely similar 
between 36hpi and 48hpi, though fewer pathways were significant at 48hpi. Up-
regulated genes, on the other hand, were primarily associated with well-known pattern 
recognition receptor (PRR) pathways (Figure 4) including the Toll-like receptor 
pathway (e.g. TLR2, TLR4, CD14, MYD88, TIRAP, and IRAK1 all up-regulated), 
the NOD-like receptor pathway (e.g. NOD1, NOD2, NLRP3 (NALP3), NLRC4 
(IPAF), NAIP (NAIP5) up-regulated) and the RIG-I-like receptor pathway (e.g. 
DDX58 (RIG-I), IFIH1 (MDA5), CYLD, DHX58 (LGP2), DDX3X, TRIM25); 
interferon signalling and cytokine and chemokine signalling pathways. Up-regulated 
inflammatory cytokine and chemokine genes included the genes encoding TNF, 
IL1A, IL1B, IL6, IL8, IL12A and IL12B, IL17B and IL17C, IL18, IL23A, IL27, 
CCL3 (MIP1α) CCL4 (MIP1β), CCL5 (RANTES), CCL8 (MCP-2) and CCL20 
(MIP3A). The genes encoding TNF, IL1B, IL6, IL12 and CCL20 were more than 10 
fold up-regulated at 36hpi. All up-regulated pathways that were significant at 36hpi 
were still significant at 48hpi, with 5 additional up-regulated pathways being 
significant only at 48hpi. These pathways were primarily related to leukocyte 
migration and phagocytosis.    
 In BIMs, only two pathways were statistically over-represented among 48hpi 
up-regulated genes - Interferon signalling and Cytokine-cytokine receptor interaction 
(Table S6). No pathways were significant at the other time-points. Among down-
regulated genes, there were also few over-represented pathways. Those pathways that 
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were significant were primarily related to the complement and focal adhesion 
pathways.  
 
Network Analysis of Differentially Expressed Genes 
 
InnateDB was used to generate a network of experimentally-supported molecular 
interactions that have been annotated to occur directly between the differentially 
expressed genes and their encoded products. Gene expression data from each of the 
four post-infection time-points was then overlaid on this network and the network 
was visualised using Cytoscape 2.8.2 (Shannon et al., 2003) (Figure 2 G-J). The 
network consisted of 2,185 nodes (representing differentially expressed genes and 
their encoded products) and 10,786 edges (representing annotated molecular 
interactions) between them.  
 The network was then analysed using cytoHubba  (Lin et al., 2008) to identify 
network hubs and bottlenecks which may represent the key regulatory nodes in the 
networks. Using the “Degree” algorithm the top 20 hubs (i.e. genes/proteins that are 
highly connected to other DE genes) in each network were identified (Table S7). 
InnateDB Gene Ontology analysis revealed that the top 20 hubs were highly enriched 
for roles in innate immunity (FDR < 1.7e-8) and transcriptional regulation (FDR < 
1.5e-7). Indeed, many of the top 20 hubs were well-known transcriptional regulators of 
innate immunity including JUN, NFKB1, RELA, STAT1, STAT3, EP300, and 
CREBBP. These transcriptional regulators were located in the most densely 
connected portion of the network and share many connections (Figure 5A). One 
interpretation of this is that transcriptional regulation by several of these transcription 
factors is required for differential gene expression in response to the infection.   
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 Bottlenecks are network nodes that are the key connector proteins in a network 
and have many “shortest paths” going through them, similar to bridges or tunnels on a 
highway map (Yu et al., 2007). 17 of the top 20 hubs were also identified as network 
bottlenecks. Beta-actin (ACTB), the transcriptional regulator, FOS (AP1), and ISG15, 
were additionally identified in the top 20 bottlenecks. ISG15 has been shown to act as 
a negative regulator of both the NFκB and RIG-I signalling pathways (Arnaud et al., 
2011; Minakawa et al., 2008)  
 Identifying hubs solely based on their degree can identify nodes that, in 
general, have been annotated to have lots of interactions. This fails to address whether 
the number of connections in a particular network of interest is more or less than is 
expected (given the number of known interactions for that node in the database and 
the size of the network). To address this issue, we have developed the Contextual Hub 
Analysis Tool (CHAT) (Wiencko et al., unpublished), a network analysis tool which 
identifies nodes in a network that are more highly connected to contextually relevant 
nodes (in this case differentially expressed nodes) than is expected by chance (Table 
S8). Applying this method to our network identified that several of the hub nodes (e.g. 
KIAA0101), did not have more connections to differentially expressed genes than 
expected by chance. This means that these genes, although highly connected, are less 
likely to be functionally important in our network. On the other hand, all of the 
transcriptional regulators of innate immunity that were identified as hubs in the 
analysis above (JUN, NFKB1, RELA, STAT1, STAT3, EP300, CREBBP), were also 
identified by CHAT to be significantly more connected to 36hpi differentially 
expressed genes than expected by chance. CHAT also identified several other known 
innate immunity transcriptional regulators in the top 20 "contextual" hubs including 
REL, IRF1, and IRF9. Indeed 15 of the top 20 contextual hubs are annotated by 
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InnateDB as having a role in innate immunity (FDR < 1.16E-12). Although the ranking 
of the top contextual hubs changed from 36 to 48hpi, the most significant hubs 
remained the same. 
 The network was also analysed using the jActiveModules plugin (Ideker et al., 
2002) in Cytoscape 2.8.2 (Shannon et al., 2003) to identify high-scoring differentially 
expressed sub-networks. This type of analysis can aid in the identification of 
functionally relevant groups of differentially expressed genes that may be acting in 
concert. A single highly connected component (>10 nodes) was identified consisting 
of 278 nodes and 1,585 interactions. This module consisted of several of the 
transcriptional hubs (CREBBP, EGR1, EP300, NFKB1, RELA) identified in the 
analysis above and their interactors (Figure 5B). Pathway analysis of genes in the 
module revealed that the module was statistically enriched for many of the same 
pathways that were identified in the analysis of all up-regulated genes including Jak-
STAT signalling, the TLR, NLR and RIG-I pathways, apoptosis, and chemokine and 
cytokine signalling (Table S9).  
 
Profiling miRNA Expression in Blood and Milk Isolated CD14+ Monocytes 
 
Sequencing of 100 miRNA Illumina libraries yielded over 1 billion reads for both the 
MIM and BIM samples. Following a pipeline of quality filtering and adaptor 
trimming, a total of 312 and 492 million reads from MIMs and BIMs, respectively, 
mapped uniquely to the Bos taurus UMD 3.1 genome (Table S2). Uniquely aligning 
reads were then assigned to known mRNAs/miRNAs using HTseq based on miRBase 
v19 annotation of the bovine genome to generate read counts per mature miRNA in 
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each sample (Flicek et al., 2012; Hubbard et al., 2009). On average, 79% of MIM 
reads and 80% of BIM reads, uniquely mapped to known miRNAs (Figure S3). 
 RNAseq profiling revealed that the miRNAome of MIMs and BIMs were 
broadly similar and exhibited a range of miRNA expression that has been observed in 
many other cell-types. 297 and 282 miRNAs were expressed at a threshold of >1 rpm 
in MIMs and BIMs, respectively (Table S10). Of these, 136 and 116, respectively, 
were expressed at a level >100 rpm, a level of expression that has been shown to be 
associated with functional miRNAs (Mullokandov et al., 2012). 
   
Multiple miRNAs are Differentially Expressed in Response to S. uberis Infection 
 
The EdgeR statistical package was utilised to determine which miRNAs were 
significantly differentially expressed in response to S. uberis infection at 12, 24, 36, 
and 48hpi. To address any normalisation issues we retained only those miRNAs that 
were robust to the normalisation procedure used (Lawless et al., 2013). Additionally, 
only miRNAs that had an average expression of >10 rpm across samples were 
included for further analysis. In MIMs, we identified that 26 unique miRNAs were 
differentially expressed. Twelve of these miRNAs were differentially expressed 
across more than one time-point (Table 1). Hierarchical clustering of the normalised 
read counts for MIM differentially expressed miRNAs revealed that the control and 
infected animals clearly separated at 36hpi (Figure 6). Very few miRNAs were 
differentially expressed in blood monocytes. We found 3 in total, 1 at 24hpi and 3 at 
48hpi (1 was differentially expressed at both time-points) (Table 1).  
 Many of the miRNAs identified as being differentially expressed have been 
shown to have a role in immunity in other species. miR-223, for example, which was 
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up-regulated at 36hpi in MIMs, has a multi-factorial role in neutrophils, regulating 
their proliferation, activation and granulopoiesis (Chen et al., 2004; Fazi et al., 2005). 
Interestingly, in RAW264.7 cells challenged with LPS, miR-223 has been reported to 
be down-regulated, allowing the up-regulation of signal transducer and activator of 
transcription 3 (STAT3), which promotes pro-inflammatory IL-6 and IL-1β 
transcription. We have previously commented on the differences in the miRNA 
response to LPS and S. uberis, a Gram-positive bacterium (Lawless et al., 2013).  
 Other DE miRNAs in our study that have a demonstrated role in immunity and 
infection in other species includes let-7e, which was down-regulated in MIMs 
following S. uberis infection. Let-7e, has been shown to regulate Caspase 3 and 7 in 
human monocyte derived macrophages infected with Mycobacterium avium 
hominissuis (Sharbati et al., 2011). Let-7e, as well as several other DE miRNAs in our 
study (bta-miR-200c, bta-miR-210, and bta-miR-193a) have also previously been 
identified as DE in bovine mammary epithelial cells stimulated with S. uberis in vitro 
(Lawless et al., 2013).  
 Another DE miRNA with a role in immune regulation is miR-150, which we 
observed to be down-regulated at both 36 and 48hpi in MIMs. miR-150 targets 
MyD88 (up-regulated at both 36 and 48hpi in MIMs), a key regulator of TLR 
signalling (Ghorpade et al., 2013). miR-150 has also been shown to target CXCR4 
(Rolland-Turner et al., 2013; Tano et al., 2011), which was up-regulated 2-fold at 36 
and 48hpi in MIMs. Finally, one of the miRNAs that was identified as down-
regulated in BIMs, miR-146b, has been shown to target TNF receptor-associated 
factor 6 (TRAF6) and IL-1 receptor-associated kinase 1 (IRAK1) genes in THP-1 
cells stimulated with LPS (Taganov et al., 2006).  
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The Predicted Targets of Down-regulated but not Up-regulated miRNAs are Highly 
Enriched for Roles in Innate Immunity  
 
To identify the potential mRNA targets of differentially expressed miRNAs in MIMs 
isolated from infected animals we identified those mRNAs whose expression was 
significantly negatively correlated with miRNA expression. These predictions were 
further refined by removing those miRNA-target predicted relationships that were not 
supported by a predicted seed region in the 3' UTR of the correlated mRNA (Figure 7, 
Table S11). Analysis of the predicted target genes using InnateDB 
(www.innatedb.com) (Lynn et al., 2008), revealed that the predicted targets of down-
regulated but not up-regulated miRNAs were highly enriched for roles in innate 
immunity (FDR < 3.2E-8). More specifically, pathway analysis revealed that down-
regulated miRNAs were predicted to preferentially target key pathogen recognition 
receptor (PRR) signalling pathways including the TLR, NLR and RIG-I signalling 
pathways (Table S12). Given that these pathways were also identified in the 
mRNAseq data as being among the top up-regulated pathways, this finding strongly 
suggests that miRNAs are key regulators of innate immune pathways which drive the 
host inflammatory response during mastitis.  
 In contrast, the predicted targets of up-regulated miRNAs were enriched for 
roles in metabolism (FDR = 0.01). Pathway analysis of the mRNAseq data had 
already highlighted the down-regulation of metabolic pathways in response to S. 
uberis infection (see above). These results suggest that miRNAs may also be key 
regulators of the transcriptional suppression of metabolic pathways during mastitis.  
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Novel miRNA discovery 
  
The miRNA sequencing data was also mined to determine if milk or blood monocytes 
expressed potentially novel miRNAs. Previously, we identified 19 novel miRNAs in 
bovine mammary epithelial cells using miRDeep2 (Lawless et al., 2013). Applying 
the same approach as our previous study we identified a further 20 high-confidence 
putatively novel bovine miRNAs that were independently predicted in multiple 
MIMs/BIMs miRNAseq data (Table S13).  
 Searching the miRBase database (v 20) using BLAST identified that 8 of the 
novel miRNAs had close homology to other miR-2284 family members. miRBase 
currently lists this miRNA family as having 102 members, yet virtually no data exists 
regarding what function such a large group of constitutively expressed miRNAs may 
have. Other novel miRNAs discovered in this study included a homolog of hsa-miR-
3680-3p, a miRNA identified in human periphery blood (Vaz et al., 2010). The 
discovery of these miRNA further adds to the database of bovine miRNAs.  
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DISCUSSION 
 
Infectious disease is a serious threat not only directly to human health but also to 
animal health, where it is associated with substantial annual economic losses, public 
confidence issues and food security concerns. Currently, there is a significant gap in 
the understanding of the molecular and genetic mechanisms which underpin 
susceptibility to infectious disease both in humans and in animals. An important 
reason for this is the fact that disease susceptibility is a multi-factorial complex 
phenotype, which is not the result of single genes acting in isolation but rather is due 
to perturbation at a network or systems level (Barabasi et al., 2011). Such networks 
are regulated at multiple different levels (e.g. genetic, transcriptional, post-
transcriptional) and as such a multi-omic integrative biology approach is needed to 
understand them. 
 Here, we report a next generation sequencing approach coupled with advanced 
network and pathway biology methods to simultaneously profile the mRNA and 
miRNA networks that are differentially regulated in vivo in blood and milk isolated 
CD14+ monocytes during infection with a bovine mastitis pathogen, S. uberis. Bovine 
mastitis is an inflammation-driven disease of the bovine mammary gland, which costs 
the global dairy industry billions of dollars per annum (Jones, 2009; Wells et al., 
1998). Profiling genome-wide changes in mRNA expression in MIMs and BIMs 
using RNAseq, we observed more than 3,500 genes to be statistically altered in their 
expression in response to S. uberis challenge. Notably, this RNAseq approach 
identified approximately 1,000 more differentially expressed genes than had been 
previously reported in a microarray based analysis of RNA expression in mammary 
tissue of cattle infected with the same pathogen (Jensen et al., 2013; Moyes et al., 
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2009; Swanson et al., 2009). As expected, given that mastitis is a relatively localised 
inflammatory disease in the mammary gland, the majority of differentially expressed 
genes were identified in MIMs, which are recruited to the site of infection. This influx 
of immune cells (including monocytes) to the site of infection was observed in 
recorded SCC data only in the infected animals. We also, however, observed a small 
but significant transcriptional response in BIMs to S. uberis infection that was 
primarily associated with an interferon and cytokine signalling signature. Previous 
studies have also shown more systemic changes in gene expression in neighbouring 
uninfected mammary glands, the liver and in the blood (Blum et al., 2000; Jensen et 
al., 2013; Jiang et al., 2008; Mitterhuemer et al., 2010).  
 The predominant signature associated with up-regulated mRNAs in MIMs 
from S. uberis infected animals was the strong transcriptional activation of innate 
immune and inflammatory gene expression. In particular, we noted the transcriptional 
activation of key pattern recognition pathways including the TLR, NLR and RIG-I 
pathways, which likely drive the observed pro-inflammatory response. The 
involvement of TLR signalling (particularly TLR 2 and 4) in the host response to 
mastitis is well documented (Buitenhuis et al., 2011; Ma et al., 2011; Mitterhuemer et 
al., 2010; Porcherie et al., 2012; Whelehan et al., 2011), however, less is known about 
the involvement of the NLR and RIG-I pathways (Moyes et al., 2009). Interestingly, 
the RIG-I pathway is classically associated with viral RNA recognition, however, 
recent findings suggest that RIG-I can also recognise nucleic acids released by 
invasive bacteria and trigger IFN-β and inflammasome activation (Abdullah et al., 
2012). These findings concur well with the observed interferon and inflammasome 
activation transcriptional signatures observed in our study.   
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 Several previous in vitro studies have strongly suggested roles for miRNAs in 
regulating bovine immunity (Dilda et al., 2011; Lawless et al., 2013), however none 
of these have globally profiled the miRNA response to infection in vivo. In this study, 
we have also used next generation sequencing to profile miRNA expression in MIMs 
and BIMs following S. uberis infection. 26 miRNAs were identified as DE in MIMs 
and 3 were identified in BIMs. Several of these have been previously described as 
targeting immune or inflammatory regulators in other species.  Of particular interest is 
our finding that down-regulated but not up-regulated miRNAs in MIMs are predicted 
to preferentially target genes involved in innate immunity and inflammation. 
Furthermore, the TLR, NLR and RIG-I pathways discussed above were all 
preferentially predicted to be targeted. This strongly suggests that the transcriptional 
suppression of these miRNAs enables the activation and amplification of the pro-
inflammatory response. Further supporting this conclusion is the fact that several of 
the DE miRNAs in our study have been validated to target genes in these pathways in 
other species. miR-149, for example, which was down-regulated in MIMs following 
S. uberis infection, has been shown to target mouse CD14 and IRAK1 (Chi et al., 
2009), key signalling proteins in the TLR pathway. Both CD14 and IRAK1 are also 
predicted to be targets of bta-miR-149 in our study.  
 The other predominant transcriptional signature that we found in MIMs 
following S. uberis infection was the wide-spread repression of a number of metabolic 
processes (> 150 KEGG-annotated metabolism genes are down-regulated at 36hpi). 
Interestingly, we found that up-regulated miRNAs were predicted to preferentially 
target genes involved in metabolism, suggesting that miRNAs, which are up-regulated 
in response to S. uberis infection may contribute to the transcriptional suppression of 
metabolic pathways. This signature of metabolic gene transcriptional suppression may 
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appear initially paradoxical in light of the fact that production of inflammatory 
cytokines is expected to require substantial energy consumption. Indeed, it is now 
becoming widely appreciated that activated macrophages undergo the Warburg effect, 
switching their metabolism from oxidative phosphorylation to glycolysis (McGettrick 
& O'Neill, 2013). This metabolic switch has recently been investigated using a 
combined metabolomics and microarray approach (Tannahill et al., 2013) and has 
revealed the up-regulation of a number of genes involved in glycolysis in bone-
marrow derived macrophages (BMDMs) challenged with lipopolysaccharide (LPS) 
(e.g. solute carrier family 2 (facilitated glucose transporter), member 1 
(SLC2A1/GLUT1), hexokinase 3 (HK3), fructose-2,6-biphosphatase 3 (PFKFB3)) and 
the down-regulation of several key genes encoding enzymes in the TCA cycle (e.g. 
malate dehydrogenase 1 (MDH1) and isocitrate dehydrogenase 2 (IDH2)). Our 
transcriptional data is very consistent with the data presented in this paper (e.g. 
SLC2A1; HK2 and HK3 and PFKFB4 are all up-regulated and MDH1 and IDH1 are 
down-regulated in MIMs at 36hpi) and suggests that although there is a broad 
signature of transcriptional suppression of metabolism, these cells are likely to be 
highly glycolytically active. Several other genes encoding enzymes in the TCA cycle 
(which was statistically over-represented among down-regulated genes) were also 
transcriptionally repressed in MIMs at 36hpi including dihydrolipoamide 
dehydrogenase (DLD); fumarate hydratase (FH); IDH3B; pyruvate dehydrogenase 
beta (PDHB); MDH2; succinate dehydrogenase complex, subunit B (SDHB); 
succinate-CoA ligase, alpha subunit (SUCLG1). As has also recently been shown in 
BMDMs, LPS strongly increases levels of succinate, a TCA cycle intermediate 
(Tannahill et al., 2013). Succinate acts as an inflammatory signal in macrophages 
inducing IL1B through the transcription factor HIF1α, both of which are 
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transcriptionally activated in MIMs 36hpi (IL1B is 10 fold up-regulated). Another 
metabolic pathway that is significantly transcriptionally repressed in MIMs at 36 and 
48hpi is the KEGG Valine, leucine and isoleucine degradation pathway. Valine, 
leucine and isoleucine are branch-chain amino acids which are converted into Acyl-
CoA derivatives. These are converted either into acetyl-CoA or succinyl-CoA and 
enter the TCA cycle (Sears et al., 2009). Most of the other significantly down-
regulated pathways including Fatty acid metabolism; Propanoate metabolism; 
Butanoate metabolism; Tryptophan metabolism; beta-Alanine metabolism; Lysine 
degradation and Glyoxylate and dicarboxylate metabolism; also result in the 
production of acetyl-CoA and succinyl-CoA that enter the TCA cycle. A similar 
pattern of expression leading to the transcriptional down-regulation of the TCA cycle 
and alternative pathways involved in producing TCA cycle components has also been 
reported in other infection models (Chin et al., 2010). The transcriptional repression 
of these pathways is therefore also consistent with a switch in metabolism from 
oxidative phosphorylation to glycolysis during the pro-inflammatory response.  
 Another pathway that is significantly down-regulated is the KEGG primary 
bile acid biosynthesis pathway. Despite the potentially misleading name, this pathway 
primarily consists of the reactions involved in cholesterol metabolism. The down-
regulation of genes involved in cholesterol metabolism has also been reported in 
monocytes isolated from HIV+ individuals (Feeney et al., 2013) and a number of 
bacterial infections (Dushkin, 2012). The accumulation of cholesterol in monocytes 
and macrophages leads to the formation of foam cells, which in humans are associated 
with the inflammatory disease, atherosclerosis (Ross, 1999). The down-regulation of 
genes involved in cholesterol and fatty acid metabolism is likely driven in part by the 
transcriptional suppression of the PPAR-γ transcription factor in MIMs at 36hpi and 
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the down-regulation of PPAR-α at 48hpi, both of which are key transcriptional 
regulators of these pathways (Dushkin, 2012). Interestingly, the PPARs also have a 
role in the regulation of inflammation, where their suppression is required to induce 
inflammatory gene expression (Bensinger & Tontonoz, 2008). Of further note is that 
one of the liver X receptors, LXR-β (NR1H2), which together with the PPARs is a 
key regulator of inflammation and lipid metabolism (Bensinger & Tontonoz, 2008), is 
up-regulated in MIMs at 36 and 48hpi. LXRs are also known to antagonise 
inflammatory gene expression, so it is somewhat surprising to find LXR-β to be up-
regulated. This may reflect the fact that balance is needed to avoid excessive 
inflammation or that LXRs and PPARs do not completely overlap in the genes that 
they regulate.   
 An additional link between metabolism and inflammation that is currently 
under intensive investigation is the role of NAD+, sirtuins (SIRTs) and AMP-
dependent protein kinase (AMPK) in suppressing inflammation (McGettrick & 
O'Neill, 2013). The activation of TLR4, which along with TLR2 and TLR9 is 
transcriptionally up-regulated in MIMs at 36hpi, has been shown to induce NAM 
phosphoribosyltransferase (NAMPT; up-regulated in MIMs at 36hpi), which in turn 
activates SIRT1 (up-regulated in MIMs at 36hpi) via NAD+. SIRT1 limits 
inflammation by repressing RELA transcription factor activity, a key transcriptional 
hub identified in MIMs. SIRT1 also activates AMPK (up-regulated in MIMs at 
36hpi), a central regulator of energy metabolism. Activation of AMPK has been 
shown to decrease NFκB activity and TNFα production in macrophages stimulated 
with LPS; IL12 production in DCs; and HIF1α. This data suggests that at 36hpi, the 
brakes are starting to be applied to limit the inflammatory response to S. uberis 
infection via SIRT1 and AMPK. The affect of this break is apparent at 48hpi where 
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the genes encoding TNFα, IL1B, IL12 and HIF1α are all down-regulated in 
comparison to 36hpi.  The limiting of inflammation at this stage makes sense based 
on the bacterial count data, which shows that bacterial CFU/ml are dropping, 
suggesting that the infection is being resolved. Interestingly, AMPK activity also 
inhibits both the cholesterol and fatty acid metabolic pathways that, as discussed 
above, are down-regulated in MIMs following S. uberis infection. This suppression of 
fatty acid metabolism has been shown to be beneficial to the host during a viral 
infection (Moser et al., 2012).   
 Finally, we also observed the statistically significant over-representation of 
down-regulated genes annotated in the KEGG glutathione metabolism pathway. 
Glutathione has an important role in innate and adaptive immunity and has been 
shown to confer protection against microbial, viral and parasitic infections (Morris et 
al., 2013). Glutathione metabolism also plays an important role in macrophages in the 
detoxification of reactive oxygen species (ROS). The transcriptional suppression of 
this pathway in MIMs following S. uberis infection may be a consequence of the 
metabolic switch to glycolysis and may be detrimental to the host leading to an excess 
of oxidants in the cells, which could drive the inflammation and tissue damage that 
are characteristic of mastitis. Indeed, in patients with active tuberculosis, PBMC 
intracellular glutathione levels dropped by 70%, this was correlated with increased 
pro-inflammatory cytokines and enhanced bacterial growth (Guerra et al., 2012). 
Supplementation with glutathione has been demonstrated to lead to the control of 
mycobacterial growth (Venketaraman et al., 2003) and also appears to have beneficial 
effects in reducing inflammation in HIV+ patients (Morris et al., 2012). This suggests 
that glutathione supplementation is a potential strategy to reduce the effects of 
inflammation in mastitis.  
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 miRNAs also likely play a key role in regulating the links between 
inflammation and metabolism observed in this study.  Human SIRT1, for example, 
which as discussed above limits inflammation, has been shown to be a target of miR-
34a (Yamakuchi et al., 2008). Our data is consistent with this relationship also 
existing in MIMs, where we have found bta-miR-34a to be down-regulated at 36 and 
48hpi and SIRT1 up-regulated. Other examples of miRNAs that likely 
transcriptionally regulate metabolic pathways in MIMs include miR-451, which is up-
regulated in MIMs at 36 and 48hpi, and has been shown to target MO25 in mouse 
heart tissue altering AMPK signalling (Chen et al., 2012). miR-451 has also been 
shown to regulate the expression of several pro-inflammatory cytokines in mice in 
response to influenza infection (Rosenberger et al., 2012).  
 Aside from providing new insight into the regulatory role miRNAs play in S. 
uberis infection in vivo, our study also provides the ground-work for a number of 
potential practical applications in veterinary medicine. miRNAs, for example, exhibit 
many properties that have made them of significant interest as non-invasive 
biomarkers. miRNAs are abundantly and stably expressed in a range of accessible 
tissues including serum, milk, urine, saliva and semen where they can be readily 
measured (Chen et al., 2010; Hata et al., 2010; Kosaka et al., 2010). Importantly for a 
potential biomarker, miRNAs have a high information content, and the expression 
profile of small numbers of them have been shown to be diagnostic of disease (De 
Guire et al., 2013). The use of miRNAs as a clinical biomarker is most advanced in 
human cancer research. In 2009, Prometheus Laboratories released a miRNA 
biomarker to accurately identify 25 different tumour types (Ajit, 2012), and miRNA 
biomarkers are now available for early cancer prognosis from two further companies 
Asuragen & Rosetta Genomics. Next generation sequencing based technologies, such 
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as the approach used in this study, are empowering RNA expression profiling, 
including miRNAs, on a genome-wide scale with unprecedented resolution, accuracy 
and speed and at a relatively low cost (Schuster, 2008). There is significant potential 
to develop these approaches as diagnostics of infection in animals but also in humans 
too.   
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Figure Legends  
 
Figure 1. Overview of the experimental design. Five Holstein Friesian animals were 
infected via the teat canal of the right front quarter with approximately 500 CFU of a 
mastitis-causing pathogen, Streptococcus uberis 0140, in 10 ml of saline. Five control 
animals were inoculated with saline only. Milk and blood samples were obtained from 
each animal at 0, 12, 24, 36 and 48 hrs post-infection (or mock infection). Milk and 
blood derived CD14+ monocytes were isolated by Fluorescence-activated cell sorting 
(FACS) from each sample. mRNA and miRNA were extracted and 200 Illumina-
compatible libraries were prepared for sequencing on a HiSeq 2000 machine. More 
than 4 billion mRNA reads and > 2 billion miRNA reads were sequenced in total.  
       
Figure 2. The response to infection. A) The infection was monitored using recorded 
milk bacterial counts (CFU/ml) and B) somatic cell counts (per ml) at each of the five 
time points (0, 12, 24, 36 and 48hpi) for each animal (control & infected). Significant 
heterogeneity was observed in the CFU data among the infected animals. One 
infected animal (TI2) was observed to have only a very modest increase in bacterial 
counts. C-F) Hierarchical clustering of top 500 most variable probes in milk-isolated 
monocytes (MIMs) at 12, 24, 36 and 48hpi, respectively, revealed that infected 
animals separated from control animals in their gene expression response at 36 and 
48hpi except for animal TI2. G-J) InnateDB network analysis of genes that were 
differentially expressed at 12, 24, 36 and 48hpi, respectively. The networks were 
visualised in Cytoscape.   
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Figure 3. Pathways that were statistically overrepresented among genes. A) up-
regulated at 36hpi; B) up-regulated at 48hpi; C) down-regulated at 36hpi; D) down-
regulated at 48hpi; in MIMs isolated from S. uberis infected animals. Up-regulated 
genes were significantly enriched for roles in inflammatory and other innate immune 
pathways, while down-regulated genes were significantly associated with metabolic 
pathways. 
 
Figure 4. Differential gene expression in key innate immune pathways in MIMs from 
S. uberis infected animals. A-C) Differentially expressed genes highlighted on KEGG 
Toll-like receptor (TLR), NOD-like receptor (NLR), and RIG-I signalling pathway 
diagrams (Red = up-regulated; Green = down-regulated). D-F) RPKM values for each 
of the differentially expressed genes in the TLR, NLR and RIG-I pathways, 
respectively (Red = infected; Blue = Control). C)  Fold change values for each of the 
differentially expressed genes in the TLR, NLR and RIG-I pathways, respectively 
(Red = up-regulated; Green = down-regulated).  
 
Figure 5. Network analysis of differentially expressed genes. InnateDB was used to 
generate a network of experimentally-supported molecular interactions that have been 
annotated to occur directly between the differentially expressed genes and their 
encoded products. A) The top 20 CytoHubba-predicted network hubs and their 
interactors. Overlain on the network is gene expression data from MIMs at 36hpi (Red 
= up-regulated; Green = down-regulated). The top 20 hubs were highly enriched for 
roles in innate immunity. B) The high-scoring differentially expressed sub-network 
identified in the larger network using jActiveModules. This module was highly 
enriched for several innate immune relevant pathways.  
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 Figure 6. A heatmap of the normalised read counts of miRNAs that were identified as 
differentially expressed in MIMs at 36hpi.  Hierarchical clustering revealed the 
separation of the infected and control animals based on this miRNA expression data. 
Note that one infected animal (TI2) is not included in this analysis as it did not appear 
to respond to the infection as measured by CFU or mRNA expression data (see Figure 
2).  
 
Figure 7. Visualization of miRNA targets. A) Two-dimensional cluster analysis and 
heatmap visualization of the miRNA/mRNA expression correlation data matrix after 
filtering by predicted miRNA-targets and correlation significance. The primary split 
in the upper hierarchical dendrogram largely aligns with the up-regulated miRNA 
(red) and down-regulated miRNA (green). miRNA/mRNA target expression 
correlations are coloured based on increasing significance (light blue to blue) with 
non-target/non-significant correlations masked (grey). B) A network representation of 
the predicted targets (circular nodes) of down-regulated miRNAs (green arrows). Red 
circles = up-regulated in MIM mRNA expression data at either 36 and/or 48hpi. 
Larger circular nodes represent those genes which have been annotated by InnateDB 
to have a role in innate immunity. C) A network representation of the predicted 
targets (circular nodes) of up-regulated miRNAs (red arrows). Green circles = down-
regulated in MIM mRNA expression data at either 36 and/or 48hpi. Note that the 
predicted targets of down-regulated but not up-regulated miRNAs are highly enriched 
for roles in innate immunity.     
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Tables 
Tissue 
Hours post 
infection (hpi) miR Name Fold change FDR 
MIMs 12 bta-miR-615 16.53 0.002591533 
MIMs 12 bta-miR-451 32.73 0.022589776 
MIMs 12 bta-miR-486 1.77 0.051194817 
MIMs 36 bta-miR-34a -8.07 0.003853138 
MIMs 36 bta-miR-200c -7.12 0.021524752 
MIMs 36 bta-miR-200b -6.59 0.022403054 
MIMs 36 bta-miR-182 -6.43 0.034621112 
MIMs 36 bta-miR-125a -5.86 0.000854468 
MIMs 36 bta-miR-200a -4.90 0.061309129 
MIMs 36 bta-let-7e -4.51 0.046884171 
MIMs 36 bta-miR-760-3p -4.38 0.030789676 
MIMs 36 bta-miR-193a-5p -4.13 0.099288316 
MIMs 36 bta-miR-150 -4.05 0.014886528 
MIMs 36 bta-miR-210 -4.03 0.000399613 
MIMs 36 bta-miR-375 -3.88 0.021524752 
MIMs 36 bta-miR-149-5p -2.77 0.099288316 
MIMs 36 bta-miR-30a-5p -2.48 0.046884171 
MIMs 36 bta-miR-142-5p 2.21 0.033031656 
MIMs 36 bta-miR-363 2.23 0.049537718 
MIMs 36 bta-miR-223 2.44 0.011440656 
MIMs 36 bta-miR-338 2.51 0.017723606 
MIMs 36 bta-miR-339a 2.82 0.01613752 
MIMs 36 bta-miR-2898 2.98 0.003853138 
MIMs 36 bta-miR-1291 3.07 0.033031656 
MIMs 36 bta-miR-423-5p 5.73 0.014512876 
MIMs 36 bta-miR-451 47.12 6.28E-07 
MIMs 48 bta-let-7e -6.92 0.055709133 
MIMs 48 bta-miR-200b -6.06 0.055709133 
MIMs 48 bta-miR-34a -5.37 0.014991858 
MIMs 48 bta-miR-149-5p -4.01 0.055709133 
MIMs 48 bta-miR-375 -3.76 0.006976206 
MIMs 48 bta-miR-210 -3.39 0.072510577 
MIMs 48 bta-miR-125a -3.29 0.087523866 
MIMs 48 bta-miR-150 -3.18 0.033651802 
MIMs 48 bta-miR-99b -2.9 0.055709133 
MIMs 48 bta-miR-338 2.81 0.055709133 
MIMs 48 bta-miR-486 12.79 0.006655283 
MIMs 48 bta-miR-451 48 1.79E-05 
BIMs 24 bta-miR-146b -23.26 0.023903261 
BIMs 48 bta-miR-451 9.74 0.067032312 
BIMs 48 bta-miR-146b -3.52 0.067032312 
BIMs 48 bta-miR-411a -22.44 0.067032312 
Table 1. Fold changes and false discovery rates of differentially expressed miRNAs at 
12, 24, 36, and 48 hours post-infection in milk and blood isolated monocytes. 
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Supplementary Information 
 
File S1. 1.1 MirVanaTM RNA Isolation Kit protocol, 1.2 MirPremierTM microRNA 
Isolation Kits protocol, 1.3 TruSeq RNA Sample Preparation Kit v2 (50 cycles), 1.4 
TruSeq Small RNA Sample Preparation Kit (50 cycles), 1.5 RNA integrity and 
quantification, 1.6 References. 
 
Figure S1. Heatmap of differential gene expression (tpm) in blood isolated 
monocytes across infected and control animals at 12, 24, 36, & 48hpi. The more red 
the colour the more highly expressed that gene is, R (V2.15.2) hclust package. 
 
Figure S2. Down-regulated genes highlighted on the KEGG metabolism network. 
 
Figure S3. The proportion of reads aligning uniquely to bovine ncRNAs. A) Reads 
aligning to ncRNAs in milk isolated monocytes. B) Reads aligning to ncRNAs in 
blood isolated monocytes. The majority of reads align to known miRNAs. 
 
Table S1. Manually generated pathway annotations for inflammasome and interferon 
pathways sourced from SA biosciences (Qiagen) RT² Profiler™ PCR Array Human 
Interferon and Receptors (PAHS-064A), and RT² Profiler™ PCR Array Human 
Inflammasome (PAHS-097A) annotations. 
 
Table S2. Summary read statistics and number of unique alignments for each RNA 
and miRNA library. 
 
 50 
Table S3. Summary of milk volumes, rectal temperatures, ambient temperatures, 
humidity, and bacterial CFU counts for each animal. Summary of total cell counts, 
FACS isolated cell numbers, RNA integrity, quantity, 18/28S ratio, total quantity of 
RNA/miRNA for each of the 100 RNA/miRNA samples. 
 
Table S4.  Average correlation coefficients of mRNA normalised read counts 
between samples at each time-point for control and infected biological replicates. 
Calculations were carried out in R (version 2.15.2). 
 
Table S5. Differentially expressed genes in milk and blood isolated monocytes at 12, 
24, 36, and 48 hours post infection.  
 
Table S6. Significantly over-represented KEGG pathways among differentially 
expressed genes in milk and blood isolated monocytes at 12, 24, 36, & 48 hours post 
infection. 
 
Table S7.  The top 20 network hubs identified using CytoHubba and enriched Gene 
Ontology terms among hubs.  
 
Table S8. The top 20 contextual hubs identified using the CHAT software.    
 
Table S9. Significantly over-represented KEGG pathways among genes identified in 
the jActiveModules module.  
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Table S10. miRNAs that are expressed > 1 tag per million in bovine blood and milk 
isolated monocytes. 
 
Table S11. Summary of co-expression, target analysis, and Pearson correlations of 
miRNA and mRNA data. 
 
Table S12. Significantly over-represented KEGG pathways among predicted miRNA 
targets.  
 
Table S13. Putative novel bovine miRNAs discovered through miRDeep2 analysis of 
miRNAseq data from 100 milk and blood isolated monocytes.  
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